Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Codexis (CDXS) Research & Development (2016 - 2025)

Codexis has reported Research & Development over the past 16 years, most recently at $11.7 million for Q4 2025.

  • Quarterly results put Research & Development at $11.7 million for Q4 2025, down 3.12% from a year ago — trailing twelve months through Dec 2025 was $52.3 million (up 13.06% YoY), and the annual figure for FY2025 was $52.3 million, up 13.06%.
  • Research & Development for Q4 2025 was $11.7 million at Codexis, down from $13.9 million in the prior quarter.
  • Over the last five years, Research & Development for CDXS hit a ceiling of $21.8 million in Q3 2022 and a floor of $11.2 million in Q4 2023.
  • Median Research & Development over the past 5 years was $13.7 million (2023), compared with a mean of $14.7 million.
  • Biggest five-year swings in Research & Development: surged 68.52% in 2022 and later plummeted 42.94% in 2023.
  • Codexis' Research & Development stood at $16.4 million in 2021, then grew by 20.37% to $19.7 million in 2022, then crashed by 42.94% to $11.2 million in 2023, then grew by 7.7% to $12.1 million in 2024, then decreased by 3.12% to $11.7 million in 2025.
  • The last three reported values for Research & Development were $11.7 million (Q4 2025), $13.9 million (Q3 2025), and $13.8 million (Q2 2025) per Business Quant data.